Sodium-Glucose Cotransporter 2 Inhibitor-Associated “Ketoacidosis” Versus “Diabetic Ketoacidosis”: The Importance of Accurate Terminology Tamara Y. MilderDavid A. MilderRichard O. Day Editorial 17 October 2023 Pages: 1303 - 1305
The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs) Mohamed A. ElhawaryComfort K. OgarHadir Rostom FROM THE ISoP 24 October 2023 Pages: 1307 - 1312
Pulmonary Toxicity Associated with Immune Checkpoint Inhibitors-Based Therapy: Current Perspectives and Future Directions Baohui HongJiabing ZhengJing Yang Systematic Review 07 November 2023 Pages: 1313 - 1322
The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands P. SlingerlandFlorence P. A. M. van HunselJ. W. Duijster Original Research Article 26 October 2023 Pages: 1323 - 1334
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study Oskar GauffinJudith S. BrandG. Niklas Norén Original Research Article Open access 07 October 2023 Pages: 1335 - 1352
Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases Johnmary T. ArinzeMaria A. J. de RidderKatia M. C. Verhamme Original Research Article Open access 31 October 2023 Pages: 1353 - 1362
Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers Patrick ChristDiana DubrallBernhardt Sachs Original Research Article Open access 21 November 2023 Pages: 1363 - 1379
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France Sibylle de GermayAllison Singieron behalf of the French Pharmacovigilance Network Original Research Article 05 November 2023 Pages: 1381 - 1389
Long-Term Real-World Post-approval Safety Data of Multiple Biosimilars from One Marketing-Authorization Holder After More than 18 Years Since Their First Biosimilar Launch Sreedhar SagiPradeep AnjaneyaHillel P. Cohen Original Research Article Open access 30 October 2023 Pages: 1391 - 1404